The ICH guidance Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality. It is also intended to help ensure that APIs meet the quality and purity characteristics that they purport, or are represented, to possess.
News & Trends
Procurar
Recentes
- FARMACOVIGILÂNCIA avançada: ““Excelente! Organizada e abrangente !”
- Study on the deployment of AI in healthcare Final report
- Boas Práticas de Fabrico . GMP 2025: “Formação foi muito útil a nível de aplicabilidade “
- Conducting Clinical Trials With Decentralized Elements. Guidance for Industry, Investigators, and Other Interested Parties
- COMMISSION IMPLEMENTING REGULATION (EU) 2025/2086 of 17 October 2025
- Main root causes of shortages: Analysis of reported root causes during 2022 & 2023
- EUDAMED Release note v 2.18.0
- The ICH E2D(R1) Guideline reaches Step 4 of the ICH Process

